MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma

[at noodls] – SAN DIEGO, Dec. 9, 2012 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities … more

View todays social media effects on MNOV

View the latest stocks trending across Twitter. Click to view dashboard

See who MediciNova is hiring next, click here to view